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A group of 124 children undergoing open-heart surgery was followed prospectively in order to
estimate the risk ofcytomegalovirus (CMV) infection due to transfused blood.
Ninety-three patients (75%) had complement fixation (CF) titers of < 1:4 against CMV on
admission. Of this seronegative subgroup, nine patients (9.7%) subsequently became infected
with CMV. All nine showed seroconversion, and six were viruric 12-14 weeks after surgery.
Comparative seroepidemiological studies of the hospital population showed that in the age
ranges studied (3-16 yr), the infections seen in the study group represented a significant excess
over expectation. This infection rate was consistent with a model of transmission by blood
transfusion with a risk of2.7% per unit but not proven.
Thirty-one patients had CF antibody to CMV on admission. CMV was isolated from 14% of
urines of seropositive children both before and after surgery, but only two patients showed CF
antibody rises to CMV. Thus the frequency of CMV infection associated with open-heart sur-
gery and transfusion could not be calculated in the seropositive subgroup.
CMV infection was not related to the primary diagnosis or to Down's syndrome.
INTRODUCTION
Since Kairiainen et al. (4) originally implicated blood transfusion in the trans-
mission of cytomegalovirus (CMV), a number of quantitative estimates of the risk
per unit ofblood have been made. Henle et al. (3) estimated that the risk ofCMV in-
fection in recipients was proportional to the number ofunits transfused and could be
estimated as 5, 10.5, and 12% per unit, respectively, for three groups of patients in
Helsinki and Philadelphia. Prince et al. (10) found that of 152 patients who received a
total of 1269 units of blood, 31 showed subsequent seroconversion and estimated the
overall risk as 2.4 seroconversions per 100 units transfused. For those receiving only
1 unit, the risk was 6.8%/unit and 0.9%/unit for those receiving 15 or more units.
Recently, Kane et al. (5) showed that 7 of 223 (3%) volunteer blood donors were
shedding CMV in the urine and that recipients of blood from three of these donors
showed serological evidence of subsequent CMV infection. In 1969, Diosi et al. (2)
were able to isolate CMV from 2 of 35 asymptomatic blood donors. These studies
strongly suggest that CMV can be transmitted by blood. However, subsequent
efforts to isolate CMV from blood involving a total of more than 800 donors have
been unsuccessful (5, 8, 15). This experience has been repeatedly confirmed by us
and by other contributors in this volume. It is possible that attempts to isolate CMV
from normal volunteer donor blood are not a useful measure ofthe risk ofblood. The
virus may exist in a form that is not readily isolated, or blood may operate in ways
other than in direct viral transmission.
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In seropositive individuals, evidence ofCMV infection following transfusion could
represent activation of latent endogenous infection by the antigenic stimulus of the
transfusion, which can be considered an allograft (7). Recently, Olding et al. (9) have
shown that the mixed leukocyte reaction as well as nonspecific mitogens will activate
murine CMV latent in leukocytes. Wu et al. (16) have shown enhancement ofchronic
murine CMV infection by application of skin allografts. Activation oflatent infection
has long been considered an important cause of the frequent CMV infections seen in
renal transplant recipients (1). Therefore, in order to exclude possible factors in-
volved in reactivation and concentrate on blood as a potential vehicle for viral trans-
mission, we chose to study CMV infection in a group oflargely seronegative children,
most of whom would not be expected to harbor latent CMV. Patients admitted to the
Children's Hospital of Pittsburgh (CHP) for open-heart surgery were identified as
such a group. These children received a variable number of units of blood and were
accessible to follow-up.
MATERIALS AND METHODS
Study Population
One hundred twenty-four children undergoing open-heart surgery at the Chil-
dren's Hospital ofPittsburgh were followed from admission through their subsequent
visits to the surgical clinic (6-8 weeks after surgery) and cardiology clinic (12-14
weeks after surgery). Blood and urine specimens were obtained prior to surgery and
at each clinic visit. Patients were unselected in that efforts were made to follow all
patients on whom presurgical specimens could be obtained during the period from
July 1972 to December 1974. Data obtained on each patient included age, sex, race,
previous admissions to the hospital, diagnosis, number of units of blood used during
the procedure.
The open-heart procedure in these patients was accomplished with a 1300-ml
Sarns heart-lung machine and Bently oxygenator. In general, 2 units (600 ml) of
packed red blood cells were used to prime the machine, although this was somewhat
variable depending on the size and hematocrit of the patient. The remaining volume
was made up with lactated Ringer's solution with 5% dextrose. While on bypass, ap-
proximately 20% of the patient's blood was sequestered in the machine, to be
returned at the end of the procedure. Additional blood requirements were met by
standard transfusion methods.
Virus Isolation
Urine was centrifuged and penicillin (200 units/ml), streptomycin (200,g/ml) and
amphotericin B (5 ,ug/ml) were added to the supernatant. The pH was adjusted to 7.0
with 4% NaHCO3 and 0.5 ml was inoculated onto duplicate monolayer cultures of
human foreskin fibroblasts (MA-184, Microbiological Associates, Inc., Bethesda,
Md.) or locally-derived human embryonic fibroblasts. Cell cultures were maintained
in Eagle's Minimal Essential Medium (MEM) supplemented with 2% fetal calf
serum and observed microscopically for viral cytopathology over an 8-week period.
Leukocytes obtained from buffy coats of heparinized blood specimens were also
inoculated into cell cultures for the first 18 months of this study. Since no specimens
from the study population yielded CMV, the practice was discontinued. Unselected
volunteer donor blood specimens were also collected for virus isolation studies.
Heparinized or EDTA-treated blood was centrifuged. The buffy coat was aspirated
in about 1 ml, and sufficient MEM was added to make 2 ml. Duplicate 0.5-ml sam-
ples were inoculated onto human fibroblast cultures as described above. When
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toxicity was seen, the cultures were "patched" by the addition of sufficient fibro-
blasts to restore the monolayer.
Serology
The complement fixation test was performed by the micromethod described by
Takatsky (12) as modified by Sever et al. (11) using commercial antigen prepared
from CMV strain AD-169 (Microbiological Associates, Inc.). Two units of antigen
and five units ofcomplement were used in the test, and the end point was taken as the
highest dilution of serum giving 1+ (25%) fixation. Titers > 1:4 were considered posi-
tive, and changes in titer > 4x were considered significant. Titers of 1:4 were uncom-
mon, occurring in about 2% of specimens. Sera were obtained from the Clinical
Chemistry and Hematology Laboratories of Children's Hospital and the Central
Blood Bank ofPittsburgh for CF antibody prevalence studies.
RESULTS
TheStudy Group
The study group ranged in age from 3-16 years with an average age of7.6. Infants
less than 3 years of age were excluded owing to the difficulty in obtaining urine
specimens. The study group was 56% male and 6% black which may be compared
with 52% male and 7% black for 484 unselected admissions in the same age range.
Twenty-five percent (31) of the study group had CF titers > 1:4 on admission, which
may be compared with 28.5% (68/239) for unselected sera obtained on admission to
CHP. Most frequent diagnoses included atrial or ventricular septal defects,
endocardial cushion defects and infundibular or valvular pulmonic stenoses.
EvidenceofCMVInfection
The evidence for CMV infection during the course of the study was an increase of
at least fourfold in CF antibody titer and/or isolation of CMV from urine. The data
are summarized in Table 1. Viruria was detected in a total of 15 patients. It can be
seen that of 31 patients seropositive at admission, five were viruric at that time and
four became viruric after surgery. This suggested that viruria was not a useful index
of acquisition of infection in seropositive children. In Table 2, the significance of
viruria is reexamined, classifying urine specimens on the basis of the serologic status
of the patient and the time of collection ofurine relative to surgery. It is clear that in
the seropositive children, about 14% were excreting CMV in the urineirrespective of
surgery or transfusion. CMV was isolated from 6 out of321 specimens obtained from
seronegative patients. Repeated positive isolations from the same patient are ex-
cluded from Table 2. All isolations were made at least 12-14 weeks after surgery. All
six seronegative patients who developed viruria also showed seroconversion, with
peak titers ranging from 1:32 to 1:256. The good correlation between viruria and se-
roconversion, and the statistically significant (x(2)= 10.894, P < .005) clustering in
the period 12-14 weeks after surgery suggests that, in contrast to the seropositive
group, development of viruria in the seronegative group was a useful indication of
newly-acquired infection. The significance of serological rise in the seropositive
patients who were not excreting CMV at the time of surgery is not clear. It is to be
noted that the rate of rise (2/26 = 7.7%) in this group is somewhat lower than the in-
fection rate of the seronegative group. This may indicate that there is some im-
munity. However, the data are insufficient. Viruria not accompanied by change in CF
antibody titer was detected in 4 of these 26 seropositive children.
There were five patients who had seroconversion alone without viruria. As shown
in Table 1, two of these were seropositive on admission and three were previously
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TABLE I
Evidence ofCMV Infection in Study Group
Number
Status on admission of
and evidence ofinfection patients
Seronegative on admission
No change 84
Viruria and Seroconversion following surgery 6
Seroconversion only 3
Seropositive and viruric on admission
No Seroconversion 5
Seropositive on admission
No change 20
Viruria following surgery, no seroconversion 4
> Fourfold CF rise following surgery 2
Totals 15 109
124
seronegative. Based on the frequency of CMV viruria in seropositive patients, the
relative rarity of serological rise, and the uncertainty of the origin ofinfection, CMV
transmission by blood transfusion was estimated only in the seronegative subgroup.
CMVInfection Rates at CHP
Although 9 out of93 (9.7%) seronegative patients showed evidence ofpostsurgical
CMV infection, usually at a time related to their surgery with concomittant transfu-
sion/perfusion, it seemed necessary to compare this rate with that seen in other
patients at CHP to determine whether it was a significant increase. Therefore, 421
sera were collected, without selection, from the clinical chemistry and hematology
laboratories. The age-specific prevalence of CMV-CF antibody titers > 1:4 is shown
in Fig. 1. Prevalence changed little over the age range of 1-16 years, averaging
29.2%. The incidence compatible with these changes in prevalence must be
substantially less than 1% per year which is, in any case, much too low to account for
the 9.7% observed in the 3-month period during which the individual members of the
study group were followed. This provides additional evidence that the CMV infec-
tions observed were related to events occurring during hospitalization. Next, an at-
tempt was made to determine the effect of hospitalization alone. Of the 421 sera in-
cluded in the prevalence survey, 182 were from patients with previous admissions to
CHP which exceeded 7 days in duration. Fifty-five (30.2%) of these patients had
CMV-CF antibody, whereas 68 out of 239 (28.5%) children who had had hospital
TABLE 2
CMV Isolation from Urines ofChildren
Undergoing Open-Heart Surgery
Timeofurine collection
CF status 6-8 weeks 12-14 weeks
on postsurgery post surgery
admission Presurgical (surgical clinic) (cardiology clinic) Totals
Seropositive 6/43a (14%) 6/40 (15%) 4/30 (13.3%) 16/113 (14.2%)
Seronegative 0/103(0%) 0/104(0%) 6/114(5.3%) 6/321 (1.9%)
Numberofvirus isolations/number ofurine specimens tested.
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FIG. 1. Age-related prevalence of CMV-CF antibody in patients admitted to Children's Hospital of
Pittsburgh. Above the histogram are the number of patients per group. All patients were over 6 months of
age.
stays of less than 7 days were seropositive. It is therefore unlikely that exposure to
the CHP environment itself caused CMV infection. These survey findings are sum-
marized in Table 3. It should be noted that in Table 3 the majority of specimens from
children categorized as having hospital stays ofless than 7 days were collected at the
time offirst admission.
The relationship between CMV infection and diagnosis is shown in Table 4, where
the status of the whole study group with respect to CMV-CF antibody and viruria
prior to surgery and subsequent evidence of CMV infection is examined. There was
no discernible correlation between diagnosis and incidence ofinfection. Although the
rate of infection (38%) for patients with pulmonic stenosis is apparently high, the
number is too small for meaningful analysis. Eight patients with Down's syndrome
were identified; one of these subsequently developed infection. In spite of the fact
that such patients are thought to have poor resistance to infections and are
frequently institutionalized, in our series they were not shown to differ from the total
study group.
TheRelationship ofCMVInfection
to NumberofUnits Transfused
As shown in Fig. 2, the number of units received by seronegative patients ranged
from 0 to 20 with a mean of 3.9. Packed erythrocytes were used almost exclusively.
We failed to isolate CMV from 120 units ofblood used in these and other patients or
from freshly drawn blood samples from 200 healthy volunteer donors. The distribu-
tion ofinfected patients according to the number ofblood units received (Fig. 2) does
not appear to indicate any dose-response relationship. However, more detailed
analysis showed that the distribution was consistent with a transmission rate ofabout
TABLE 3
CMV-CF Antibody Prevalence in Unselected Sera from CHP
Length of CMV-CF Antibody
stay at CHP Positive Negative Totals
< 7 days 68 (28.5%) 171 239
> 7 days 55 (30.2%) 127 182
Totals 123 (29.2%) 298 421
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TABLE 4
CMV Infections According to Diagnosis
Preoperative status Postoperative
Numberof Viruric CF> 1:4 CMV infection
Diagnosis patients CF> 1:4 (no viruria) Number Percentage
Atrial septal defect 32 0 5 3 9.3
Ventricular septal defect 23 2 4 2 8.7
TetralogyofFallot 18 0 5 2 11.1
Aortic stenosis 17 2 5 3 17.6
Transposition ofthe
great vessels 8 0 4 0 0.0
Endocardial cushion defect 8 1 2 1 12.5
Pulmonic stenosis 8 0 0 3 37.5
Other 10 1 2 1 10.0
Total 124 5 27 15 12.1
Down's syndromea 8 1 1 1 12.5
aDown's Syndrome was not a diagnosis indicating open-heart surgery and these patients are included in
the categories above.
2.7% per unit of blood. The calculations were made as follows: Ifp equals the frac-
tion ofall blood units that contains CMV, and m equals the number ofunits received
by a recipient, then P, the probability ofreceiving blood containing CMV, isgiven as:
P = 1 - (1 - p)m
For example, if5% ofthe units contain CMV and a patient received 20 units, P = 1 -
(1 - .05)20 = .6415.
This method of analysis was applied to the data of Fig. 2 using the observed num-
bers of patients in the study group receiving the number ofblood units shown. It was
found that forp = .027, the total expected number ofinfections was 9.2 for the study
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FIG. 2. Blood units received by open-heart surgery patients who were seronegative at admission. Those
patients who became infected are shown by cross-hatched bars. The plain histogram represents the total
group. x= mean.
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FIG. 3. Relationship between blood transfusion and CMV infection in patients seronegative on ad-
mission. The number of infections are plotted as a cumulative function of the number of units received.
Circles and solid line: Observed data. Broken line: Theoretical model assuming a risk of transmission of
2.7%/unit (see text). Dotted line: Theoretical model assuming independence between number of units
transfused and risk ofinfections in which all patients have a risk of9.68% (see text).
population. That is, 2; ni(I - [1 - 0.027] "i) = 9.2 where niis the number ofpatients
receiving mi units of blood. The theoretical cumulative distribution curve derived in
this manner is shown, together with the observed values, in Fig. 3. The third curve in
this figure is based on an independent model in which each patient has the same
probability (9/93 = .0968) of acquiring CMV infection. The three curves are not
statistically distinguishable (Kolmogorov-Smirnov test) and hence we can only say
that our results are consistent with a model in which 2.7% ofthe blood units are capa-
ble of transmission of CMV. We cannot, from this analysis, eliminate the possibility
ofinvolvement ofother factors in the CMV infections observed.
DISCUSSION
Evaluation of the role of blood transfusion in the transmission of CMV has been
complicated by the recognized ability of this virus to remain latent in man and to be
reactivated by modification of the host-parasite relationship (6, 14). We have there-
fore depended only upon data derived from the seronegative subpopulation to esti-
mate CMV transmission by blood. In actuality, the data from our seropositive
patients were intrinsically unreliable since viruria was shown to occur with equal fre-
quency before and after transfusion. Rises in antibody titer must also be viewed with
suspicion in seropositive patients in view ofthe temporal variation in CMV-CF titers
reported by Waner and Weller (13) in patients undergoing plasmapheresis.
We believe that the nine infections seen in seronegative children are probably pri-
mary, although it is possible that those detected by seroconversion only may repre-
sent reactivations or normal fluctuations in titer not associated with new infection. It
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is likely that viruria could have been detected in association with seroconversion if
urine samples had been obtainable more frequently.
Seroepidemiological studies of the general hospital population showed that our
study group was very similar to the total hospital population in terms of age, race,
and prevalence ofCMV-CF antibody. The low annual incidence rate ofCMV (< 1%
year) in the age group studied, estimated from the prevalence data, enabled us to
conclude that the observed incidence (9.7% over a 3-month period or 40% per year)
in the seronegative study group represented a real excess ofinfection occurring after
transfusion.
The observed infection rate of2.7% per unit ofblood administered to seronegative
recipients is surprisingly similar to the estimate made by Kane et al. (5) that 3% of
healthy volunteer donors are viruric and possibly capable of transmitting CMV, al-
though we, like many others (5, 8, 15) were unable to detect CMV in blood. The find-
ings of Diosi et al. (2) that a proportion of asymptomatic donors yield CMV from
their blood remains to be confirmed with American volunteer donor populations.
Nonetheless, our results are consistent with transmission by blood although dose-
responsiveness could not be statistically established.
Our estimate of the risk ofacquiring CMV by blood transfusion cannot bedirectly
compared with estimates made by Henle et al. (3) and Prince et al. (10). These esti-
mates considered both seropositive and seronegative patients and the mathematical
model used, although correct for single-unit transfusion, was not well adapted for
estimation of risk in multiple-unit transfusions.
Examining physicians reported no clinically important morbidity attributable to
CMV infection in our study group.
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